NCT02430012View on ClinicalTrials.gov

Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention

NACompletedINTERVENTIONAL
Enrollment

10,009

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 18, 2016

Study Completion Date

September 30, 2017

Conditions
Coronary Artery Bypass GraftingSecondary Preventions
Interventions
BEHAVIORAL

Quality improvement strategies

Training with guidelines of secondary preventions; determining improvement goals; tools (workflow posters and cards, checklists to inform the use of secondary prevention medications); periodical quality feedback report.

Trial Locations (1)

100037

China National Center for Cardiovascular Diseases, Beijing

All Listed Sponsors
lead

China National Center for Cardiovascular Diseases

OTHER_GOV

NCT02430012 - Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention | Biotech Hunter | Biotech Hunter